It is now clear that metastasis, the process by which the primary tumor gets into the bloodstream and spreads to distant organs where it implants and grows, ultimately causes the death of most cancer patients (greater than 80 percent).

Currently, there are no FDA-approved drugs that directly block metastasis in solid tumor cancers.

Our therapeutic strategy blocks tumor stemness which has the potential to prevent metastasis while blocking tumor progression.

Safe and effective therapeutics that can prevent or reverse metastasis would represent a fundamental breakthrough in cancer therapy, which would fulfill a major unmet medical need.